ciprofloxacin has been researched along with Intestinal Diseases in 11 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Intestinal Diseases: Pathological processes in any segment of the INTESTINE from DUODENUM to RECTUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Diclofenac is a non-steroidal anti-inflammatory drug (NSAID), which may cause serious intestinal adverse reactions (enteropathy)." | 1.43 | Ciprofloxacin blocked enterohepatic circulation of diclofenac and alleviated NSAID-induced enteropathy in rats partly by inhibiting intestinal β-glucuronidase activity. ( Chen, Y; Li, Y; Ling, ZL; Liu, L; Liu, XD; Shu, N; Sun, BB; Tang, XG; Wang, F; Xia, LZ; Xie, QS; Xu, P; Zhang, M; Zhao, KJ; Zhong, ZY, 2016) |
| "Amikacin was less effective." | 1.30 | Comparison of ceftriaxone, amikacin, and ciprofloxacin in treatment of experimental Yersinia enterocolitica O9 infection in mice. ( Gonzalez-Torres, C; Jiménez-Valera, M; Moreno, E; Ruiz-Bravo, A, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (18.18) | 18.7374 |
| 1990's | 4 (36.36) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Zutter, A | 1 |
| Maes, B | 1 |
| Dedeurwaerdere, F | 1 |
| Zhong, ZY | 1 |
| Sun, BB | 1 |
| Shu, N | 1 |
| Xie, QS | 1 |
| Tang, XG | 1 |
| Ling, ZL | 1 |
| Wang, F | 1 |
| Zhao, KJ | 1 |
| Xu, P | 1 |
| Zhang, M | 1 |
| Li, Y | 1 |
| Chen, Y | 1 |
| Liu, L | 1 |
| Xia, LZ | 1 |
| Liu, XD | 1 |
| Seddik, H | 1 |
| Ahtil, R | 1 |
| En-Nouali, H | 1 |
| El Khattabi, A | 1 |
| El Mansari, O | 1 |
| Samie, A | 1 |
| Guerrant, RL | 1 |
| Barrett, L | 1 |
| Bessong, PO | 1 |
| Igumbor, EO | 1 |
| Obi, CL | 1 |
| Peralta, S | 1 |
| Accursio, A | 1 |
| Filaci, G | 1 |
| Vitale, B | 1 |
| D'Aiello, G | 1 |
| Scarsi, C | 1 |
| Collura, D | 1 |
| Rini, GB | 1 |
| Sidorenko, SV | 1 |
| Jiménez-Valera, M | 1 |
| Gonzalez-Torres, C | 1 |
| Moreno, E | 1 |
| Ruiz-Bravo, A | 1 |
| Trenschel, R | 1 |
| Peceny, R | 1 |
| Runde, V | 1 |
| Elmaagacli, A | 1 |
| Dermoumi, H | 1 |
| Heintschel von Heinegg, E | 1 |
| Müller, KD | 1 |
| Schaefer, UW | 1 |
| Beelen, DW | 1 |
| Mashilov, VP | 1 |
| Avdeeva, LA | 1 |
| Kaluzhina, TI | 1 |
| Brodov, LE | 1 |
| Golokhvastova, EL | 1 |
| Iakovleva, ON | 1 |
| Alikeeva, GK | 1 |
| Eng, RH | 1 |
| Smith, SM | 1 |
| Lo, W | 1 |
| Lowe, WC | 1 |
| Lähdevirta, J | 1 |
2 reviews available for ciprofloxacin and Intestinal Diseases
| Article | Year |
|---|---|
[Ciprofloxacin in the treatment of intestinal infections of bacterial etiology].
Topics: Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Drug Resistance, Microbial; Dysentery, B | 1997 |
Ciprofloxacin in the elimination of enteric Salmonella carriage stage.
Topics: Carrier State; Ciprofloxacin; Humans; Intestinal Diseases; Salmonella Infections | 1989 |
1 trial available for ciprofloxacin and Intestinal Diseases
| Article | Year |
|---|---|
Fungal colonization and invasive fungal infections following allogeneic BMT using metronidazole, ciprofloxacin and fluconazole or ciprofloxacin and fluconazole as intestinal decontamination.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antifungal Agents; Aspergillosis; | 2000 |
8 other studies available for ciprofloxacin and Intestinal Diseases
| Article | Year |
|---|---|
A Multifocal Abdominal Mass in a Renal Transplant Recipient.
Topics: Aged; Anti-Bacterial Agents; Biopsy; Ciprofloxacin; Escherichia coli Infections; Female; Humans; Imm | 2017 |
Ciprofloxacin blocked enterohepatic circulation of diclofenac and alleviated NSAID-induced enteropathy in rats partly by inhibiting intestinal β-glucuronidase activity.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cattle; Ciprofloxacin; Diclofenac; Dose-Response R | 2016 |
[Small-bowel gangrene revealing a Yersinia pseudotuberculosis infection].
Topics: Anti-Bacterial Agents; Ciprofloxacin; Female; Gangrene; Humans; Intestinal Diseases; Intestine, Smal | 2009 |
Prevalence of intestinal parasitic and bacterial pathogens in diarrhoeal and non-diarroeal human stools from Vhembe district, South Africa.
Topics: Adult; Animals; Anti-Infective Agents; Bacteria; Ceftriaxone; Child; Ciprofloxacin; Cross-Sectional | 2009 |
Ciprofloxacin in the treatment of infections at different sites.
Topics: Anti-Bacterial Agents; Bacterial Infections; Ciprofloxacin; Escherichia coli Infections; Female; Hum | 1989 |
Comparison of ceftriaxone, amikacin, and ciprofloxacin in treatment of experimental Yersinia enterocolitica O9 infection in mice.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Feces; Female; Intestinal Dise | 1998 |
[Experience in using new drug preparations for treating adult patients with acute intestinal infections].
Topics: Acute Disease; Adult; Anti-Infective Agents, Local; Carrier State; Ciprofloxacin; Drug Combinations; | 1990 |
Eradication of non-typhi Salmonella colonization by ciprofloxacin: implications for health care workers and institutionalized patients.
Topics: Adult; Aged; Ciprofloxacin; Feces; Female; Health Workforce; Humans; Institutionalization; Intestina | 1990 |